Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Zhibao Technology's Subsidiary, Zhibao Health, Launches the "Ren Ren Kang Yue" Product in Collaboration with the People's Insurance Company of China

By: Newsfile

Shanghai, China--(Newsfile Corp. - September 17, 2025) - Zhibao Technology Inc. (NASDAQ: ZBAO) ("Zhibao," "we," or the "Company"), a leading and high growth InsurTech company primarily engaging in providing digital insurance brokerage services through its operating entities in China, today announced its wholly owned subsidiary Zhibao Health, has officially launched the "Ren Ren Kang Yue" product in collaboration with the People's Insurance Company of China ("PICC") on August 26, 2025.

This new product is a middle-market medical insurance product designed to cover the needs of urban residents, between the ages of 20-50 years old, within China. With a slogan of "mid-end prices, high-end quality," this product includes convenient services including direct billing, access to the VIP or International wards of public hospitals in China, and access to selected private providers, while remaining affordable to meet the needs of young professionals and families. Within the Chinese medical system, VIP and International wards provide access to premium medical services within the setting of the wider hospital, allowing patients access to high-end services while still retaining access to the doctors and resources of leading public hospitals.

This offering will be sold through three separate channels, including PICC's nationwide sales network, as well as through Zhibao's subsidiary, Sunshine Insurance Brokers, in addition to third-party channels and platforms.

The "Ren Ren Kang Yue" product extends PICC's own "Ren Ren An Kang" product line, a social medical insurance supplemental policy, and provides existing customers with an additional upgrade option during their renewal cycle. This product represents the first in a series of strategic cooperation products with PICC as both companies are committed to providing affordable, high-quality medical insurance products across China.

"I am pleased to announce a new insurance product line with our PICC partner that delivers healthcare services to a wider, more diverse population, and promotes the Company's mission of providing affordable healthcare coverage through various technology channels to China's middle class. We believe our strategic partnership with PICC underscores Zhibao's long-standing commitment to providing innovative insurance solutions and driving growth within the Chinese insurance market. We look forward to strengthening and deepening our relationship with one of China's largest P&C insurance companies across medical and other product lines in the future," said Mr. Botao Ma, Chief Executive Officer of Zhibao Technology.

The "Ren Ren Kang Yue" product went live on Monday, August 18, 2025, with the first policies being issued the same day. We believe this product is designed to provide high quality, yet affordable coverage with plans starting at RMB 840/USD $117 per year.

In December 2024, the Company announced a strategic partnership with PICC to launch a new generation of medical insurance products in China. This collaboration was expected to leverage the strengths of both partners to deliver a comprehensive and innovative medical insurance solution tailored to meet the needs of China's growing middle class.

We believe Zhibao's deep knowledge of the Chinese insurance market and its technological expertise are central to the development of this product, as well as to customer service and claims processing. We believe the Company's extensive medical network further ensures efficient, high-quality healthcare services for policyholders nationwide. 

About Zhibao Technology Inc.

Zhibao Technology Inc. (NASDAQ: ZBAO) is a leading and high growth InsurTech company primarily engaging in providing digital insurance brokerage services through its operating entities ("Zhibao China Group") in China. 2B2C ("to-business-to-customer") digital embedded insurance is the Company's innovative business model, which Zhibao China Group pioneered in China. Zhibao China Group launched the first digital insurance brokerage platform in China in 2020, which is powered by their proprietary PaaS ("Platform as a Service").

Zhibao has developed over 40 proprietary and innovative digital insurance solutions addressing different scenarios in a wide range of industries, including but not limited to travel, sports, logistics, utilities, and e-commerce. Zhibao acquires and analyzes customer data, utilize big data and AI technology to continually iterate and enhance its digital insurance solutions. This iterative process, in addition to continually improving its digital insurance solutions, will keep it abreast of the new trends and customer preferences in the market. For more information, please visit: ir.zhibao-tech.com.

Forward-Looking Statements

Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "is/are likely to," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations that arise after the date hereof, except as may be required by law. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions, and other factors discussed in the "Risk Factors" section of our annual reports on Form 20-F (as amended) and registration statements on Form F-1 (as amended) and Form F-3 (as amended) that have been filed or will be filed from time to time with the SEC. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statements and other filings with the SEC. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov.

Investor Relations Contact

Zhibao Technology Inc.
Investor Relations
Office Email: ir@zhibao-tech.com

Skyline Corporate Communications Group, LLC
Scott Powell, President
Avenues Tower 1177 Avenue of the Americas, 5th floor
New York, NY 10036
Office: (646) 893-5835
Email: info@skylineccg.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/266806

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.